Literature DB >> 18418226

Management of expected and unexpected opioid-related side effects.

Juan-Diego Harris1.   

Abstract

Intolerable side effects contribute to poor outcomes among patients managed with opioids, and negotiating these side effects remains an important clinical challenge. Evidence-based approaches to minimizing the side-effect burden from opioids compiled from the literature, and including clinical practice recommendations, focus on (1) reducing the doses of systemic opioids, (2) managing the adverse symptoms of opioids, (3) integrating opioid rotation, and (4) changing the route of administration. These broad strategies, and specific recommendations for individual side effects of opioids, including those that often go unrecognized within the following organ systems: neurologic, cardiopulmonary, gastrointestinal, urologic, endocrinologic, dermatologic, and immunologic, are considered herein. In addition, specific patient populations, opioid metabolites, and clearance issues are considered. In particular, novel medications and better alternatives to preexisting treatments for specific opioid side effects, such as peripheral opioid antagonists, may ameliorate the management of patients taking long-term opioid therapies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418226     DOI: 10.1097/AJP.0b013e31816b58eb

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  15 in total

Review 1.  Acupuncture for the treatment of cancer pain: a systematic review of randomised clinical trials.

Authors:  Tae-Young Choi; Myeong Soo Lee; Tae-Hun Kim; Christopher Zaslawski; Edzard Ernst
Journal:  Support Care Cancer       Date:  2012-03-25       Impact factor: 3.603

Review 2.  Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.

Authors:  Kirsten M Raehal; Cullen L Schmid; Chad E Groer; Laura M Bohn
Journal:  Pharmacol Rev       Date:  2011-08-26       Impact factor: 25.468

3.  Four Strategies for Managing Opioid-Induced Side Effects in Older Adults.

Authors:  Emma Rogers; Sonal Mehta; Rose Shengelia; Manney Carrington Reid
Journal:  Clin Geriatr       Date:  2013-04

4.  Evaluation of the role of opium addiction in acute myocardial infarction as a risk factor.

Authors:  Mohammad Reza Khosoosi Niaki; Mahdizadeh Hamid; Fatemeh Farshidi; Mehdi Mohammadpour; Mohammad Taghi Salehi Omran
Journal:  Caspian J Intern Med       Date:  2013

Review 5.  Bone cancer pain: from mechanism to therapy.

Authors:  Patrick W Mantyh
Journal:  Curr Opin Support Palliat Care       Date:  2014-06       Impact factor: 2.302

Review 6.  Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids.

Authors:  Annette L van Ojik; Paul A F Jansen; Jacobus R B J Brouwers; Eric N van Roon
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

7.  A period of immobility after remifentanil administration protects from nausea: an experimental randomized cross-over study.

Authors:  Fabian Heuser; Christian M Schulz; Alexander Hapfelmeier; Nadine Lehnen; Eberhard F Kochs; Klaus J Wagner
Journal:  BMC Anesthesiol       Date:  2016-10-10       Impact factor: 2.217

8.  Association between prescribed central nervous system depressant drugs, comorbidity and cognition among hospitalised older patients: a cross-sectional study.

Authors:  Tahreem Ghazal Siddiqui; Socheat Cheng; Michael Gossop; Espen Saxhaug Kristoffersen; Ramune Grambaite; Christofer Lundqvist
Journal:  BMJ Open       Date:  2020-07-27       Impact factor: 2.692

Review 9.  Management of chronic pain in elderly, frail patients: finding a suitable, personalized method of control.

Authors:  Rahul Rastogi; Brian D Meek
Journal:  Clin Interv Aging       Date:  2013-01-16       Impact factor: 4.458

10.  A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain.

Authors:  Magdi Hanna; John Thipphawong
Journal:  BMC Palliat Care       Date:  2008-10-31       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.